Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)

HKG:9989 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	17,748	15,060	16,905	19,320	27,970	28,112
Market Cap Growth	6.55%	-10.92%	-12.50%	-30.93%	-0.50%	3.28%
Enterprise Value	17,810	16,448	21,024	22,600	29,804	30,748
Last Close Price	5.38	3.73	3.37	5.02	7.44	10.64
PE Ratio	38.65	21.88	-	23.49	94.63	23.11
PS Ratio	3.02	2.69	2.83	2.39	3.58	4.44
PB Ratio	1.31	1.16	1.28	1.38	1.98	2.03
P/TBV Ratio	1.68	1.49	1.66	1.81	2.62	2.71
P/FCF Ratio	9.61	7.10	-	-	-	-
P/OCF Ratio	8.81	6.45	38.53	-	-	634.89
EV/Sales Ratio	3.03	2.94	3.51	2.79	3.82	4.86
EV/EBITDA Ratio	20.69	15.05	180.70	15.71	22.01	20.11
EV/EBIT Ratio	32.63	20.72	-	20.02	29.13	25.54
EV/FCF Ratio	9.65	7.75	-	-	-	-
Debt / Equity Ratio	0.25	0.29	0.46	0.52	0.49	0.48
Debt / EBITDA Ratio	3.32	3.33	38.64	4.95	4.98	4.28
Debt / FCF Ratio	1.83	1.78	-	-	-	-
Asset Turnover	0.31	0.29	0.27	0.36	0.33	0.31
Inventory Turnover	0.73	0.58	0.67	0.84	1.11	1.19
Quick Ratio	1.16	1.09	0.76	0.94	1.19	1.52
Current Ratio	2.39	2.60	2.13	2.22	2.25	2.53
Return on Equity (ROE)	3.23%	5.17%	-6.58%	5.97%	2.01%	10.66%
Return on Assets (ROA)	2.27%	2.55%	-0.68%	3.13%	2.73%	3.70%
Return on Capital (ROIC)	2.50%	2.80%	-0.75%	3.46%	3.02%	4.07%
Return on Capital Employed (ROCE)	4.90%	5.50%	-	6.60%	5.80%	6.60%
Earnings Yield	2.59%	4.57%	-5.10%	4.26%	1.06%	4.33%
FCF Yield	10.40%	14.09%	-0.26%	-5.73%	-0.88%	-0.74%
Dividend Yield	5.08%	7.13%	-	2.25%	0.58%	1.67%
Payout Ratio	68.39%	-	-	34.51%	171.31%	43.69%
Buyback Yield / Dilution	0.56%	0.54%	-0.67%	-0.05%	-8.42%	-8.51%
Total Shareholder Return	5.63%	7.67%	-0.67%	2.20%	-7.84%	-6.84%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.